Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

The evidence for symptomatic treatments in amyotrophic lateral sclerosis.

Jenkins TM, Hollinger H, McDermott CJ.

Curr Opin Neurol. 2014 Oct;27(5):524-31. doi: 10.1097/WCO.0000000000000135. Review.

PMID:
25110934
2.

Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions.

Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, Milo M, Hollinger HC, Walsh T, Highley JR, Olpin S, McDermott CJ, Shaw PJ, Kirby J.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):201-26. doi: 10.1111/nan.12147.

3.

Assessing social isolation in motor neurone disease: a Rasch analysis of the MND Social Withdrawal Scale.

Gibbons CJ, Thornton EW, Ealing J, Shaw PJ, Talbot K, Tennant A, Young CA; UKMND-QoL Group..

J Neurol Sci. 2013 Nov 15;334(1-2):112-8. doi: 10.1016/j.jns.2013.08.002. Epub 2013 Aug 9.

4.

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.

UKMND-LiCALS Study Group., Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Murphy CL, Al-Chalabi A, Dougherty A, Leigh PN, Wijesekera L, Thornhill M, Ellis CM, O'Hanlon K, Panicker J, Pate L, Ray P, Wyatt L, Young CA, Copeland L, Ealing J, Hamdalla H, Leroi I, Murphy C, O'Keeffe F, Oughton E, Partington L, Paterson P, Rog D, Sathish A, Sexton D, Smith J, Vanek H, Dodds S, Williams TL, Steen IN, Clarke J, Eziefula C, Howard R, Orrell R, Sidle K, Sylvester R, Barrett W, Merritt C, Talbot K, Turner MR, Whatley C, Williams C, Williams J, Cosby C, Hanemann CO, Iman I, Philips C, Timings L, Crawford SE, Hewamadduma C, Hibberd R, Hollinger H, McDermott C, Mils G, Rafiq M, Shaw PJ, Taylor A, Waines E, Walsh T, Addison-Jones R, Birt J, Hare M, Majid T.

Lancet Neurol. 2013 Apr;12(4):339-45. doi: 10.1016/S1474-4422(13)70037-1. Epub 2013 Feb 27. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

5.

Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.

Kirby J, Highley JR, Cox L, Goodall EF, Hewitt C, Hartley JA, Hollinger HC, Fox M, Ince PG, McDermott CJ, Shaw PJ.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):562-71. doi: 10.1111/nan.12007.

6.

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS..

BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111.

7.

Evaluation of two different methods for per-oral gastrostomy tube placement in patients with motor neuron disease (MND): PIG versus PEG procedures.

Chavada G, El-Nayal A, Lee F, Webber SJ, McAlindon M, Walsh T, Hollinger H, McDermott CJ, Shaw PJ.

Amyotroph Lateral Scler. 2010 Dec;11(6):531-6. doi: 10.3109/17482968.2010.494306. Epub 2010 Jun 16.

PMID:
20553092
8.

Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis.

Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, Williams TL, Ince PG, McDermott CJ, Shaw PJ.

Arch Neurol. 2010 Apr;67(4):455-61. doi: 10.1001/archneurol.2010.52.

PMID:
20385912
9.

Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).

Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ.

PLoS One. 2010 Mar 24;5(3):e9872. doi: 10.1371/journal.pone.0009872.

10.

Pattern of spread and prognosis in lower limb-onset ALS.

Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ, Talbot K.

Amyotroph Lateral Scler. 2010 Aug;11(4):369-73. doi: 10.3109/17482960903420140.

11.

Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis.

Kirby J, Goodall EF, Smith W, Highley JR, Masanzu R, Hartley JA, Hibberd R, Hollinger HC, Wharton SB, Morrison KE, Ince PG, McDermott CJ, Shaw PJ.

Neurogenetics. 2010 May;11(2):217-25. doi: 10.1007/s10048-009-0218-9. Epub 2009 Sep 17.

PMID:
19760257
12.

[Does the transplant of a transfused cadaver donor function better than one from a non-transfused donor?].

Harder F, Müller M, Buchs JB, Descoeudres C, Hollinger HP, Ruegsegger CH, Sege D, Brunner F.

Helv Chir Acta. 1984 Apr;51(1):127-30. German. No abstract available.

PMID:
6373677
13.

[Diffuse telangiectasias of the gastric antrum with and without cirrhosis of the liver as a cause of chronic gastrointestinal bleeding (author's transl)].

Schläpfer HU, Hammer B, Kobler E, Deyhle P, Gloor F, Sulser H, Hollinger H, Ammann R.

Schweiz Rundsch Med Prax. 1982 Mar 2;71(9):355-9. German. No abstract available.

PMID:
6978485
14.

Isolation of human reagins differing in their affinity for ragweed immunosorbent.

Kisil FT, Attallah NA, Sehon AH, Hollinger HZ.

Int Arch Allergy Appl Immunol. 1974;46(3):448-57. No abstract available.

PMID:
4213669
15.

In vitro and in vivo inactivation of reagins with mercaptans.

Kisil FT, Sehon AH, Hollinger HZ.

Clin Allergy. 1971 Dec;1(4):387-97. No abstract available.

PMID:
5005948
16.

Hypogammaglobulinemia, thymoma and ulcerative colitis.

Hollinger HZ.

Can Med Assoc J. 1967 Jun 17;96(24):1584-6. No abstract available.

17.

A review of calcium and phosphorus metabolism. II. Hypocalcaemia.

HOLLINGER HZ, PATTEE CJ.

Can Med Assoc J. 1957 Jul 1;77(1):45-53. No abstract available.

18.

Localization of blocking antibody in sera of ragweed-sensitive individuals by starch electrophoresis.

SEHON AH, HOLLINGER HZ, HARTER JG, SCHWEITZER AE, ROSE B.

J Allergy. 1957 May;28(3):229-37. No abstract available.

PMID:
13428485
19.

A review of abnormal calcium and phosphorus metabolism. I. Hypercalcaemia.

HOLLINGER HZ, PATTEE CJ.

Can Med Assoc J. 1956 Dec 1;75(11):941-8. No abstract available.

20.

Effect of acetazoleamide (diamox) and phytin on calcinosis universalis.

DELANEY FG, HOLLINGER HZ, PATTEE CJ.

Can Med Assoc J. 1956 Aug 15;75(4):292-5. No abstract available.

Supplemental Content

Loading ...
Support Center